Unlock instant, AI-driven research and patent intelligence for your innovation.

Applications of 1-benzyl-4-(2,4-dichloro phenethylamino)piperidine in preparation of antitumor medicines

A kind of dichlorophenethylamino and benzyl technology, which is applied in the application field of 1-benzyl-4-(2,4-dichlorophenethylamino) piperidine in the preparation of antitumor drugs

Active Publication Date: 2015-07-08
南京诺文海泰生物医药有限公司
View PDF5 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Except for MLN4924, there are currently no other types of NEDD8 activating enzyme inhibitors that have entered clinical trials, let alone any NEDD8 activating enzyme inhibitors on the market. Therefore, finding and developing new NEDD8 activating enzyme inhibitors will be of great significance for cancer treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Applications of 1-benzyl-4-(2,4-dichloro phenethylamino)piperidine in preparation of antitumor medicines
  • Applications of 1-benzyl-4-(2,4-dichloro phenethylamino)piperidine in preparation of antitumor medicines
  • Applications of 1-benzyl-4-(2,4-dichloro phenethylamino)piperidine in preparation of antitumor medicines

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Example 1: The inhibitory activity of M22 on NEDD8 activating enzyme was detected by western blot.

[0032] Add 2 μL NEDD8 activating enzyme (2.5 μM), 2 μL NEDD8 (250 μM), 2 μL Abc12 (50 μM) and 10 μL M22 aqueous solution (0-90 μM) in a series of concentration ranges into a 100 μL tube. After mixing the reaction solution evenly, incubate at 37°C for 10 min. Then 2 μL of Mg-ATP (1.25 μM) solution was added. After the reaction solution was mixed evenly, it was incubated at 37°C for 1 h. After the reaction was completed, 2 μL of EDTA (1 mM) aqueous solution was added to terminate the reaction. Protein samples were collected, and the protein level of Ubc12-NEDD8 in the reaction system was detected by western blot. The results showed that M22 dose-dependently inhibited the production of Ubc12-NEDD8 and effectively inhibited the activity of NEDD8 activating enzyme, see figure 1 .

Embodiment 2

[0033] Example 2: ATP competition experiment.

[0034]Add 2 μL NEDD8 activating enzyme (2.5 μM), 2 μL NEDD8 (250 μM), 2 μL Abc12 (50 μM) and 10 μL M22 aqueous solution (33.3 μM) into a 100 μL tube. After mixing the reaction solution evenly, incubate at 37°C for 10 min. Then add 2 μL of Mg-ATP solution of different concentrations (1.25-10000 μM). After the reaction solution was mixed evenly, it was incubated at 37°C for 1 h. After the reaction was completed, 2 μL of EDTA (1 mM) aqueous solution was added to terminate the reaction. Protein samples were collected, and the protein level of Ubc12-NEDD8 in the reaction system was detected by western blot. The results showed that with the increase of ATP concentration, the content of Ubc12-NEDD8 gradually increased, and the activity of NEDD8 activating enzyme was restored. To illustrate that M22 is an ATP-competitive inhibitor of NEDD8 activating enzyme, see figure 2 .

Embodiment 3

[0035] Example 3: Western Blot detection of the effect of M22 on the activity of NEDD8 activating enzyme in cells.

[0036] Western Blot was used to detect the effects of different concentrations of M22 (0-90 μM) on the contents of intracellular related proteins Uba3-NEDD8 (the complex of NEDD8 activating enzyme β subunit and NEDD8) and Ubc12-NEDD8 after the A549 cells were treated for 24 hours. The results show that M22 has a dose-dependent inhibitory effect on the generation of Uba3-NEDD8 and Ubc12-NEDD8 on lung cancer A549, see image 3 . The compound can inhibit NEDD8 activating enzyme activity at the cellular level.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of medicines, particularly relates to applications of 1-benzyl-4-(2,4-dichloro phenethylamino)piperidine or pharmaceutically acceptable salts or pharmaceutically acceptable carriers thereof in preparation of medicines used for preventing or treating diseases related to NEDD8 kinase abnormity, and more particularly relates to applications of the 1-benzyl-4-(2,4-dichloro phenethylamino)piperidine in preparation of antitumor medicines. Pharmacological results show that: the compound has good NEDD8 inhibiting activity, good tumor cell proliferation resistance, a good function of promoting tumor cell apoptosis and good in-vivo antitumor activity, and can be used for prepare medicines treating tumor clinically.

Description

technical field [0001] The invention relates to the application of 1-benzyl-4-(2,4-dichlorophenethylamino)piperidine or a pharmaceutically acceptable salt thereof in the preparation of antitumor drugs. Background technique [0002] Malignant tumors are a large class of common multiple diseases that seriously endanger human health, with a high fatality rate, second only to cardiovascular and cerebrovascular diseases. According to the statistics of the World Health Organization, about 8.2 million people died of cancer in the world in 2012, and it is estimated that the number of deaths due to cancer will exceed 11 million in 2030. China is a country with a high incidence and mortality rate of cancer, which causes economic losses of hundreds of billions of yuan every year, and with the aging of the population, the deterioration of the ecological and living environment, this trend is more likely to intensify. Therefore, finding effective drugs for the treatment of tumors has att...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4468A61P35/00A61P35/02
Inventor 王玉斌陆鹏袁新睿秦慧
Owner 南京诺文海泰生物医药有限公司